Augmedix (OTCMKTS:AUGX) Trading Down 2.7%

Augmedix, Inc. (OTCMKTS:AUGX)’s stock price was down 2.7% on Wednesday . The stock traded as low as $0.74 and last traded at $0.75. Approximately 257,406 shares traded hands during trading, a decline of 54% from the average daily volume of 558,973 shares. The stock had previously closed at $0.77.

Augmedix Price Performance

The company has a debt-to-equity ratio of 3.74, a quick ratio of 1.70 and a current ratio of 1.70. The firm has a market cap of $37.75 million, a price-to-earnings ratio of -1.79 and a beta of -0.27. The company’s fifty day moving average is $1.87 and its two-hundred day moving average is $3.73.

Augmedix (OTCMKTS:AUGX) last released its quarterly earnings results on Monday, May 13th. The company reported ($0.12) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.12). Augmedix had a negative net margin of 57.70% and a negative return on equity of 980.09%. The firm had revenue of $13.47 million for the quarter, compared to the consensus estimate of $13.25 million. Equities research analysts forecast that Augmedix, Inc. will post -0.48 EPS for the current year.

About Augmedix

Augmedix, Inc provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits.